Table 2.
Overall AGREE-HS scores
|
P-value |
||||||
|---|---|---|---|---|---|---|
|
|
Raw total score, median (IQR)*
|
Transformed total score, median (IQR)†
|
Overall
|
CDC vs ECDC
|
CDC vs WHO
|
ECDC vs WHO
|
|
Overall
|
32.0 (26.0-42.0) |
36.7 (26.7-53.3) |
|
|
|
|
|
Organisation
|
|
|
<0.001‡ | <0.001‡ | <0.001‡ | 0.455‡ |
| CDC |
24.0 (22.0-27.0) |
23.3 (20.0-28.3) |
||||
| ECDC |
35.0 (31.0-39.0) |
41.7 (35.0-48.3) |
||||
| WHO |
37.0 (32.0-45.5) |
45.0 (36.7-59.2) |
|
|
|
|
|
Pandemic
|
|
|
0.015§ | - | - | - |
| H1N1 |
27.0 (25.8-30.0) |
28.3 (26.3-33.3) |
- | - | - | - |
| COVID-19 | 33.5 (26.8-42.3) | 39.2 (27.9-53.8) | - | - | - | - |
AGREE-HS – Appraisal of Guidelines for Research and Evaluation – Health Systems, IQR – interquartile range, WHO – World Health Organization, ECDC – European Centre for Disease Control and Prevention, CDC – United States Centers for Disease Control and Prevention
*Median score for both assessors (range = 10-70), with 40 being considered as the mid-point.
†Calculated per the formula obtained score – minimum score/maximum score – minimum score as per the AGREE-HS manual [17].
‡Kruskal-Wallis test for overall and Dwass-Steel-Critchlow-Fligner test for pairwise comparison.
§Mann-Whitney’s U test.